Menu
Search
|

Menu

Close
X

Natus Medical Inc BABY.OQ (NASDAQ Stock Exchange Global Select Market)

33.46 USD
+0.07 (+0.21%)
As of Nov 20
chart
Previous Close 33.39
Open 33.14
Volume 192,045
3m Avg Volume 81,489
Today’s High 33.76
Today’s Low 32.99
52 Week High 41.55
52 Week Low 27.70
Shares Outstanding (mil) 33.15
Market Capitalization (mil) 1,340.90
Forward P/E 67.43
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.67 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY18
390
FY17
501
FY16
382
FY15
376
EPS (USD)
FY18
-0.342
FY17
0.005
FY16
1.333
FY15
1.141
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
67.43
33.59
Price to Sales (TTM)
vs sector
3.01
5.69
Price to Book (MRQ)
vs sector
3.14
5.11
Price to Cash Flow (TTM)
vs sector
32.57
23.52
Total Debt to Equity (MRQ)
vs sector
25.67
15.71
LT Debt to Equity (MRQ)
vs sector
25.67
11.53
Return on Investment (TTM)
vs sector
3.83
15.05
Return on Equity (TTM)
vs sector
4.58
16.62

EXECUTIVE LEADERSHIP

Robert Gunst
Independent Chairman of the Board, Since 2004
Salary: --
Bonus: --
Jonathan Kennedy
President, Chief Executive Officer, Director, Since 2018
Salary: $490,000.00
Bonus: --
Drew Davies
Chief Financial Officer, Executive Vice President, IR Contact Officer, Since 2018
Salary: --
Bonus: --
Carsten Buhl
President & CEO, Otometrics Strategic Business Unit, Since 2018
Salary: --
Bonus: --
Sharon Villaverde
Vice President - Finance, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

6701 Koll Center Pkwy Ste 120
PLEASANTON   CA   94566-8061

Phone: +1925.2236700

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The Company is organized into three strategic business units: Neurology, Newborn Care and Otometrics.

SPONSORED STORIES